Laura E Mitchell Selected Research

Spinal Dysraphism (Spina Bifida)

2/2015	Air toxics and birth defects: a Bayesian hierarchical approach to evaluate multiple pollutants and spina bifida.
9/2013	Exon sequencing of PAX3 and T (brachyury) in cases with spina bifida.
3/2011	Maternal exposure to ambient levels of benzene and neural tube defects among offspring: Texas, 1999-2004.
8/2010	Genetic and lifestyle variables associated with homocysteine concentrations and the distribution of folate derivatives in healthy premenopausal women.
8/2009	Folate and homocysteine phenotypes: Comparative findings using research and clinical laboratory data.
10/2008	Genetic and biochemical determinants of serum concentrations of monocyte chemoattractant protein-1, a potential neural tube defect risk factor.
8/2006	Loss of function polymorphisms in NAT1 protect against spina bifida.
5/2006	Maternal genotype for the monocyte chemoattractant protein 1 A(-2518)G promoter polymorphism is associated with the risk of spina bifida in offspring.
7/2005	The NAT1 C1095A polymorphism, maternal multivitamin use and smoking, and the risk of spina bifida.
11/2004	Spina bifida.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Laura E Mitchell Research Topics

Disease

14	Congenital Abnormalities (Deformity) 01/2019 - 04/2008
13	Neural Tube Defects (Exencephaly) 01/2019 - 06/2004
13	Spinal Dysraphism (Spina Bifida) 02/2015 - 11/2002
8	Congenital Heart Defects (Congenital Heart Defect) 02/2022 - 09/2009
4	Cardiovascular Diseases (Cardiovascular Disease) 09/2009 - 04/2008
3	Obesity 01/2019 - 01/2013
3	Neoplasms (Cancer) 01/2017 - 09/2015
3	Hyperhomocysteinemia 10/2009 - 06/2004
2	Type 2 Diabetes Mellitus (MODY) 01/2019 - 08/2009
2	Insulin Resistance 01/2014 - 08/2009
2	Gastroschisis 08/2013 - 06/2012
2	Cleft Palate (Palate, Cleft) 08/2005 - 02/2005
2	Cleft Lip (Harelip) 08/2005 - 02/2005
1	DiGeorge Syndrome (Syndrome, DiGeorge) 01/2020
1	Celiac Disease (Celiac Sprue) 01/2019
1	Hypoxia (Hypoxemia) 01/2019
1	Fibrosis (Cirrhosis) 01/2019
1	Hypertension (High Blood Pressure) 01/2019
1	Weight Loss (Weight Reduction) 01/2018
1	Weight Gain 01/2018
1	Fatty Liver 01/2018
1	Body Weight (Weight, Body) 01/2018
1	Primitive Neuroectodermal Tumors (PNET) 09/2015
1	Medulloblastoma 09/2015
1	Astrocytoma (Pilocytic Astrocytoma) 09/2015
1	Hyperglycemia 01/2014
1	Hyperthermia 10/2013
1	Gestational Diabetes (Gestational Diabetes Mellitus) 01/2013
1	Pathologic Constriction (Stenosis) 11/2012
1	Choanal Atresia 11/2012
1	Clubfoot (Talipes Equinovarus) 09/2011
1	Anencephaly (Aprosencephaly) 03/2011
1	Pregnancy Complications 03/2011
1	Tetralogy of Fallot (Fallot Tetralogy) 11/2010
1	Holoprosencephaly (Arhinencephaly) 09/2009
1	Glucose Intolerance 08/2009
1	Ventricular Heart Septal Defects (Ventricular Septal Defect) 12/2008
1	Conotruncal cardiac defects 12/2008

Drug/Important Bio-Agent (IBA)

23	Folic Acid (Vitamin M)FDA LinkGeneric 01/2019 - 11/2002
9	HomocysteineIBA 08/2010 - 11/2002
7	beta-cyclodextrin tetradecasulfate (CTDS)IBA 02/2022 - 11/2010
4	Benzene (Benzole)IBA 01/2017 - 03/2011
4	Air Pollutants (Pollutants, Air)IBA 01/2017 - 03/2011
3	Glucose (Dextrose)FDA LinkGeneric 01/2018 - 08/2009
2	1,3-butadiene (divinyl)IBA 01/2017 - 09/2015
2	Polycyclic Aromatic Hydrocarbons (Polynuclear Aromatic Hydrocarbons)IBA 11/2012 - 06/2012
2	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 10/2008 - 05/2006
1	ChromatinIBA 01/2019
1	Genetic Markers (Genetic Marker)IBA 01/2019
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2019
1	RNA (Ribonucleic Acid)IBA 01/2019
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2019
1	LactaseIBA 01/2019
1	Non-Receptor Type 1 Protein Tyrosine PhosphataseIBA 01/2018
1	Leptin ReceptorsIBA 01/2018
1	Pro-Opiomelanocortin (Proopiomelanocortin)IBA 01/2018
1	LeptinIBA 01/2018
1	PesticidesIBA 01/2017
1	Drinking WaterIBA 01/2017
1	Cisplatin (Platino)FDA LinkGeneric 10/2016
1	Particulate MatterIBA 09/2015
1	Trichloroethylene (Trichloroethene)IBA 02/2015
1	quinolineIBA 02/2015
1	Environmental Pollutants (Pollutants, Environmental)IBA 02/2015
1	Brachyury protein (Brachyury)IBA 09/2013
1	ORALIT (ORS)IBA 08/2013
1	Histones (Histone)IBA 06/2013
1	Anticonvulsants (Antiepileptic Drugs)IBA 01/2013
1	Thyroxine (Levothyroxine)FDA LinkGeneric 11/2012
1	Contractile ProteinsIBA 09/2011
1	Xylenes (Xylene)IBA 03/2011
1	ethylbenzeneIBA 03/2011
1	TolueneIBA 03/2011
1	Biological ProductsIBA 09/2009
1	LigandsIBA 09/2009
1	arsenic acid (arsenate)IBA 08/2009
1	Insulin (Novolin)FDA Link 08/2009
1	ArsenicIBA 08/2009
1	A-Form DNA (A-DNA)IBA 02/2009
1	Messenger RNA (mRNA)IBA 10/2008
1	ChemokinesIBA 10/2008
1	EnzymesIBA 08/2006
1	Transforming Growth Factor alpha (TGF-alpha)IBA 08/2005
1	Transforming Growth Factor beta3 (TGF beta 3)IBA 08/2005
1	SmokeIBA 07/2005
1	DNA (Deoxyribonucleic Acid)IBA 02/2005
1	Leucovorin (Folinic Acid)FDA Link 09/2004
1	5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase (Methyltetrahydrofolate Homocysteine Methyltransferase)IBA 11/2002
1	methionine synthase reductaseIBA 11/2002
1	Methionine (L-Methionine)FDA Link 11/2002

Therapy/Procedure

1	Bariatric Surgery 11/2018
1	Operative Surgical Procedures 11/2018
1	Therapeutics 01/2018
1	Baths 10/2013
1	Steam Bath (Sauna) 01/2013